Ptosis (Blepharoptosis) in Adults Medication

Updated: Jul 10, 2020
  • Author: Adam J Cohen, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print
Medication

Medication Summary

The FDA approved oxymetazoline ophthalmic solution in July 2020 for the treatment of acquired blepharoptosis in adults.

Next:

Alpha Agonists, Ophthalmic

Class Summary

The FDA approved oxymetazoline ophthalmic solution in July 2020 for the treatment of acquired blepharoptosis in adults.

Oxymetazoline ophthalmic (Upneeq)

Indicated for acquired blepharoptosis in adults.

Previous